Changeflow GovPing Pharma & Drug Safety Rodent Model for Neurodegenerative Disorders
Routine Notice Added Final

Rodent Model for Neurodegenerative Disorders

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

European Patent Office published patent application EP4030896A1 for Neuro-Bio Ltd's rodent model for neurodegenerative disorders. The patent covers classifications A01K 67/027, C07K 14/47, and C12N 9/18. The application designates all major EPO member states including DE, FR, GB, IT, ES, NL, and 29 others.

What changed

The EPO published patent application EP4030896A1 filed by Neuro-Bio Ltd for a rodent model useful in studying neurodegenerative disorders. Inventor is Susan Greenfield. The patent covers specific biological compositions and methods related to C07K 14/47 (polypeptides) and C12N 9/18 (enzymes). The designation extends to 35 European states including AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.\n\nThis is a routine patent publication notice with no compliance obligations for third parties. Parties developing similar animal models or working in the neurodegenerative disease research space should review this publication for potential freedom-to-operate considerations. No action is required unless conducting commercial activities that may infringe the claims once granted.

Source document (simplified)

← EPO Patent Bulletin

RODENT MODEL FOR NEURODEGENERATIVE DISORDERS

Publication EP4030896A1 Kind: A1 Mar 25, 2026

Applicants

Neuro-Bio Ltd

Inventors

GREENFIELD, Susan

IPC Classifications

A01K 67/027 20060101AFI20250819BHEP C07K 14/47 20060101ALI20250819BHEP C12N 9/18 20060101ALI20250819BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4030896A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Industry sector
3254.1 Biotechnology 3254 Pharmaceutical Manufacturing
Activity scope
Patent Application
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.